The introduction of electronic medical records in France: More progress during the second attempt.

To support care coordination, a national electronic medical record (DMP), has been created by law in 2004. Because of technical difficulties and delays during implementation, the project was entrusted to a dedicated technical agency in 2009. But 3 years later, only 160,000 DMPs had been opened contrary to the several million expected. Physicians criticized the technical and administrative burden, but the main factors highlighted were resistance to sharing information with patients and with other professionals. Failing to cross the critical threshold of users that gives value to the system, the project failed. After this first attempt, the project was entrusted by law to the national health insurance fund in 2016. The new policy was addressed to patients, professionals and software companies. The policy has allowed patients to independently access and modify their DMP data already in possession of the national public medical insurance, and has introduced financial incentives for physicians opening a DMP. As a result the deployment of DMPs has accelerated substantially: 350,000 new DMPs were opened in nine pilot departments within a year. If scaled-up to the entire country, this number would correspond to 4 million DMPs.

Telemedicine: what framework, what levels of proof, implementation rules.

The concept of telemedicine was formalised in France in the 2009 "Hospital, patients, health territories" (loi hôpital, patients, santé, territoire) law and the 2010 decree through which it was applied. Many experiments have been carried out and the regulatory institutions (Ministry, Regional Health Agency [Agence régionale de santé, ARS], French National Health Authority [Haute autorité de santé, HAS], etc.) have issued various guidance statements and recommendations on its organisation and on the expectations of its evaluation. With this background, the round table wanted to produce recommendations on different areas of medical telemonitoring (the role of telemonitoring, the regulatory system, the principles for assessment, methods of use and conditions for sustained and seamless deployment). Whilst many studies carried out on new medical telemonitoring approaches have led to the postulate that it offers benefit, both clinically and in terms of patient quality of life, more information is needed to demonstrate its impact on the organisation of healthcare and the associated medico-economic benefit (criteria, methods, resources). Similarly, contractual frameworks for deployment of telemonitoring do exist, although they are complicated and involve many different stakeholders (Director General fo the Care Offering [Direction générale de l'offre de soins, DGOS], ARS, HAS, Agency for Shared Health Information Systems [Agence des systèmes d'information partagés de santé, ASIP], French National Data Protection Commission [Commission nationale informatique et libertés, CNIL], French National Medical Council [Conseil national de l'Ordre des médecins, CNOM], etc.) that would benefit from a shared approach and seamless exchange between the partners involved. The current challenge is also to define the conditions required to validate a stable economic model in order to promote organisational change. One topical issue is placing the emphasis on its evaluation and operation. Access to patient data, particularly data from the health insurance funds and the use of these data, may enable the process to be more effective. In addition, the budgetary non-fungibility of the various financial envelopes for the different areas of work, restricts the consolidation of financial impact. Funding methods will need to be adapted to this new distribution of roles, both at the centre of the healthcare system and in the industrial ecosystem. All of these changes will help the leaders of our healthcare system to bring this new ambition closer to all of the people working in the health economy.